All the news Showing 10 of 54 articles from: Hepatitis C eliminationGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Keith Alcorn / 30 April 2019 The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people who inject drugs and people in prisons. In an analysis ... Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment Keith Alcorn / 24 April 2019 Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing an internationally agreed target set by the World Health Organization, The International Liver Congress ... $51 billion price tag for eliminating hepatitis C by 2030 Keith Alcorn / 11 April 2019 To achieve hepatitis C elimination worldwide by 2030, governments, donors and the private sector will need to spend $51 billion but eliminating hepatitis C will lead to a $19 billion ... Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up Liz Highleyman / 07 March 2019 New cases of hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men seen at three clinics in London have declined by nearly 70% since 2015, according to a presentation yesterday ... Tackling HIV and hepatitis C in Europe: towards minimum standards Gus Cairns / 11 February 2019 Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of a European-wide ... Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... WHO hepatitis C elimination targets are achievable, model shows – if 51 million treated by 2030 Keith Alcorn / 29 January 2019 Expanding hepatitis C screening to diagnose 90% of people by 2030, providing treatment to everyone with hepatitis C, scaling up harm reduction and improving blood and medical safety would avert ... Lancet commission sets agenda for the elimination of viral hepatitis Keith Alcorn / 10 January 2019 Viral hepatitis leads to around 1.3 million deaths a year, approximately 257 million people are living with hepatitis B virus (HBV) and 71 million with hepatitis C virus (HCV). Viral hepatitis ... Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs Michael Carter / 26 November 2018 Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. ... ← Prev1...23456Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive